MediaRadar Blog

M&A Report: WeMLO, Binary Tree and IM HealthScience In the news

M&A Report: WeMLO, Binary Tree and IM HealthScience In the News

In keeping with our mission to provide comprehensive advertising analysis, MediaRadar puts together a report of the most important mergers and acquisitions news each week. Stay in the loop, whether you sell advertising space or focus on business development. 

This week, RE/MAx gained fintech startup Wemlo and Quest Software purchased Binary Tree. Nestle Health Science is growing on multiple fronts, including its acquisition of IM HealthScience.

MediaRadar Blog Signup

RE/MAX acquired fintech startup Wemlo

RE/MAX Holdings, Inc., along with its sister company Motto Mortgage have completed an acquisition of the fintech start-up company Wemlo. Wemlo provides third-party mortgage loan processing services. 

The 20-month-old company is credited for developing the first “Service Cloud” for mortgage brokers, and is the only enterprise-grade solution of its kind in the mortgage brokerage market. 

Combining Wemlo with Motto Mortgage, a mortgage brokerage franchise, will help to increase the speed and efficiency of the mortgage loan processing, creating an opportunity for Motto Mortgage to expand its business. The financial terms of the acquisition have not been released. 

Quest Software purchased Microsoft partner Binary Tree 

Quest Software, a global systems management and security software provider announced it acquired long-time Microsoft partner Binary Tree. 

Binary Tree offers cloud migration software and SaaS solutions to help enterprises transform and manage change with the Microsoft cloud. Similarly, Quest Software offers end-to-end solutions for migration, management, and security across all Microsoft platforms through its Microsoft Platform Management

Following the acquisition, Quest will continue to sell and support Binary Tree products as the company integrates its services into its current platform. The financial terms of the deal have not been made public.  

Nestle Health Science expands with IM HealthScience 

Nestle Health Science completed its acquisition of IM HealthScience and its sister company, Physician’s Seal. IM HealthScience produces medical foods that help with IBS, Functional Dyspepsia, Diverticulosis, Ulcerative colitis, and Crohn’s Disease. 

Its brands now under Nestle Health Science management include IBgard, FDgard, Fiber Choice, and REMfresh. 

Nestle Health Science already contains a large portfolio of brands including Garden of Life, Boost, Pure Encapsulations, and Vitaflo. The company has experience acquiring brands and using its financial resources to develop and expand in the market. Terms of the acquisition have not been disclosed. 

In Other News

Other deals are pending or unfortunately getting rejected:

  • Nestle Health Science also struck a deal to acquire the biotechnology company Aimmune Therapeutics for $2.6 billion. 
  • Unilever has entered into an agreement to acquire hydration powder mix brand Liquid IV. Liquid I.V. uses its trademarked Cellular Transport Technology to produce powders for hydration, energy, and sleep.
  • U.S.-based NerdWallet, which provides financial advice and resources for people looking for a credit card, loan, insurance, and other financial products, is acquiring U.K. price comparing site Know Your Wallet. 
  • Clayton, Dubilier & Rice (CD&R) announced that it is acquiring business management software company Epicor Software from KKR & Co. Inc. for $4.7 billion including debt. 
  • Archant Limited, the largest publisher of regional and local lifestyle magazines and digital media in the U.K., is close to being sold to private equity firm Rcaptial Partner. 
  • According to the Wall Street Journal, AT&T is looking to sell its digital advertising operations Xandr in yet another potential move to trim down assets to offset its huge debt pile. 
  • Earlier this week, American cable television provider Altice USA, Inc. announced that it has offered to acquire all outstanding shares of Canadian telecommunications and media company Cogeco Inc. and Cogeco Communications Inc. for $7.8 billion, only to be rejected.